drugset / Trial / NCT02578472
Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of the study is to evaluate the effects of JNJ-42847922, compared to zolpidem and placebo, on driving performance as assessed by the mean difference of standard deviation of lateral position (SDLP) after forced awakening using a validated driving simulator test at 2, 4, 6 and 8 hours post-evening dose.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seltorexant | Small molecule | 40 mg | Oral |
| Subject | Zolpidem | Small molecule | 10 mg | Oral |
Indications
No indication recorded.